Matches in SemOpenAlex for { <https://semopenalex.org/work/W2107040566> ?p ?o ?g. }
- W2107040566 abstract "Women with triple-negative breast cancer have the worst prognosis, frequently present with metastatic tumors and have few targeted therapy options. Notch-1 and Notch-4 are potent breast oncogenes that are overexpressed in triple-negative and other subtypes of breast cancer. PEA3, an ETS transcription factor, is also overexpressed in triple-negative and other breast cancer subtypes. We investigated whether PEA3 could be the critical transcriptional activator of Notch receptors in MDA-MB-231 and other breast cancer cells.Real-time PCR and Western blot analysis were performed to detect Notch-1, Notch-2, Notch-3 and Notch-4 receptor expression in breast cancer cells when PEA3 was knocked down by siRNA. Chromatin immunoprecipitation was performed to identify promoter regions for Notch genes that recruited PEA3. TAM-67 and c-Jun siRNA were used to identify that c-Jun was necessary for PEA3 enrichment on the Notch-4 promoter. A Notch-4 luciferase reporter was used to confirm that endogenous PEA3 or AP-1 activated the Notch-4 promoter region. Cell cycle analysis, trypan blue exclusion, annexin V flow cytometry, colony formation assay and an in vivo xenograft study were performed to determine the biological significance of targeting PEA3 via siRNA, Notch signaling via a γ-secretase inhibitor, or both.Herein we provide new evidence for transcriptional regulation of Notch by PEA3 in breast cancer. PEA3 activates Notch-1 transcription in MCF-7, MDA-MB-231 and SKBr3 breast cancer cells. PEA3 activates Notch-4 transcription in MDA-MB-231 cells where PEA3 levels are endogenously high. In SKBr3 and BT474 breast cancer cells where PEA3 levels are low, overexpression of PEA3 increases Notch-4 transcripts. Chromatin immunoprecipitation confirmed the enrichment of PEA3 on Notch-1 and Notch-4 promoters in MDA-MB-231 cells. PEA3 recruitment to Notch-1 was AP-1-independent, whereas PEA3 recruitment to Notch-4 was c-JUN-dependent. Importantly, the combined inhibition of Notch signaling via a γ-secretase inhibitor (MRK-003 GSI) and knockdown of PEA3 arrested growth in the G1 phase, decreased both anchorage-dependent and anchorage-independent growth and significantly increased apoptotic cells in vitro. Moreover, either PEA3 knockdown or MRK-003 GSI treatment significantly reduced tumor growth of MDA-MB-231 xenografts in vivo.Taken together, the results from this study demonstrate for the first time that Notch-1 and Notch-4 are novel transcriptional targets of PEA3 in breast cancer cells. Targeting of PEA3 and/or Notch pathways might provide a new therapeutic strategy for triple-negative and possibly other breast cancer subtypes." @default.
- W2107040566 created "2016-06-24" @default.
- W2107040566 creator A5041301571 @default.
- W2107040566 creator A5048441743 @default.
- W2107040566 creator A5058263437 @default.
- W2107040566 creator A5065893637 @default.
- W2107040566 creator A5082872372 @default.
- W2107040566 date "2011-06-01" @default.
- W2107040566 modified "2023-10-07" @default.
- W2107040566 title "NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications" @default.
- W2107040566 cites W125937443 @default.
- W2107040566 cites W1508234976 @default.
- W2107040566 cites W1525502277 @default.
- W2107040566 cites W1578907646 @default.
- W2107040566 cites W1606273823 @default.
- W2107040566 cites W1844485434 @default.
- W2107040566 cites W1861588860 @default.
- W2107040566 cites W1969803272 @default.
- W2107040566 cites W1971398874 @default.
- W2107040566 cites W1975487351 @default.
- W2107040566 cites W1975730939 @default.
- W2107040566 cites W1978285772 @default.
- W2107040566 cites W1988081818 @default.
- W2107040566 cites W1990434941 @default.
- W2107040566 cites W1990713247 @default.
- W2107040566 cites W1990725971 @default.
- W2107040566 cites W1994471759 @default.
- W2107040566 cites W1994760694 @default.
- W2107040566 cites W1997215642 @default.
- W2107040566 cites W1997801717 @default.
- W2107040566 cites W1999463736 @default.
- W2107040566 cites W2004512249 @default.
- W2107040566 cites W2005400237 @default.
- W2107040566 cites W2006996147 @default.
- W2107040566 cites W2013503399 @default.
- W2107040566 cites W2015794035 @default.
- W2107040566 cites W2019007505 @default.
- W2107040566 cites W2021456586 @default.
- W2107040566 cites W2021824240 @default.
- W2107040566 cites W2026305659 @default.
- W2107040566 cites W2028236537 @default.
- W2107040566 cites W2030812135 @default.
- W2107040566 cites W2037579198 @default.
- W2107040566 cites W2039642932 @default.
- W2107040566 cites W2041140906 @default.
- W2107040566 cites W2048486094 @default.
- W2107040566 cites W2052947465 @default.
- W2107040566 cites W2052977964 @default.
- W2107040566 cites W2053009900 @default.
- W2107040566 cites W2054740212 @default.
- W2107040566 cites W2062711358 @default.
- W2107040566 cites W2065820769 @default.
- W2107040566 cites W2068668144 @default.
- W2107040566 cites W2076711667 @default.
- W2107040566 cites W2082533656 @default.
- W2107040566 cites W2082872266 @default.
- W2107040566 cites W2085948054 @default.
- W2107040566 cites W2092123619 @default.
- W2107040566 cites W2097928089 @default.
- W2107040566 cites W2112060629 @default.
- W2107040566 cites W2112348715 @default.
- W2107040566 cites W2113844650 @default.
- W2107040566 cites W2114213130 @default.
- W2107040566 cites W2115504447 @default.
- W2107040566 cites W2121047246 @default.
- W2107040566 cites W2126375034 @default.
- W2107040566 cites W2133660369 @default.
- W2107040566 cites W2143958554 @default.
- W2107040566 cites W2147135997 @default.
- W2107040566 cites W2147373929 @default.
- W2107040566 cites W2152302317 @default.
- W2107040566 cites W2163171497 @default.
- W2107040566 cites W2163638464 @default.
- W2107040566 cites W2164406730 @default.
- W2107040566 cites W2312647513 @default.
- W2107040566 cites W2318605753 @default.
- W2107040566 doi "https://doi.org/10.1186/bcr2900" @default.
- W2107040566 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3218952" @default.
- W2107040566 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21679465" @default.
- W2107040566 hasPublicationYear "2011" @default.
- W2107040566 type Work @default.
- W2107040566 sameAs 2107040566 @default.
- W2107040566 citedByCount "60" @default.
- W2107040566 countsByYear W21070405662012 @default.
- W2107040566 countsByYear W21070405662013 @default.
- W2107040566 countsByYear W21070405662014 @default.
- W2107040566 countsByYear W21070405662015 @default.
- W2107040566 countsByYear W21070405662016 @default.
- W2107040566 countsByYear W21070405662017 @default.
- W2107040566 countsByYear W21070405662018 @default.
- W2107040566 countsByYear W21070405662019 @default.
- W2107040566 countsByYear W21070405662020 @default.
- W2107040566 countsByYear W21070405662021 @default.
- W2107040566 countsByYear W21070405662022 @default.
- W2107040566 countsByYear W21070405662023 @default.
- W2107040566 crossrefType "journal-article" @default.
- W2107040566 hasAuthorship W2107040566A5041301571 @default.
- W2107040566 hasAuthorship W2107040566A5048441743 @default.
- W2107040566 hasAuthorship W2107040566A5058263437 @default.
- W2107040566 hasAuthorship W2107040566A5065893637 @default.